USD 0.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 25.31 | 25.31 | -3.00 | 25.31 | - | - |
Net Income | -25.3 Thousand | -25.3 Thousand | -25.3 Thousand | -25.3 Thousand | -25.27 Thousand | -25.27 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 25.3 Thousand | 25.3 Thousand | 25.3 Thousand | 25.3 Thousand | - | - |
Other non-cash items | 25.31 | 25.31 | 25.31 | 25.31 | 25.27 Thousand | 25.27 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 25.3 Thousand | - | - | - | - | - |
Cash at beginning of period | 2976.00 | 2976.00 | 2979.00 | 2979.00 | 2979.00 | 2979.00 |
Cash at end of period | 2976.00 | 2976.00 | 2976.00 | 2979.00 | 2979.00 | 2979.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -3.00 | - | - | - |
Free Cash Flow | 25.31 | 25.31 | -3.00 | 25.31 | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6320.00 | -6320.00 | -6346.00 | -25.3 Thousand | -6346.00 | -6320.00 |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 6320.00 | 6320.00 | 6346.00 | 25.3 Thousand | 6346.00 | 6320.00 |
Other non-cash items | 6320.00 | 6320.00 | 6.35 | 25.31 | 6.35 | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 6320.00 | - | - | - | - | - |
Cash at beginning of period | 2976.00 | 2976.00 | 2976.00 | 2976.00 | 2976.00 | 2976.00 |
Cash at end of period | 2976.00 | 2976.00 | 2976.00 | 2976.00 | 2976.00 | 2976.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | 6.35 | 25.31 | 6.35 | - |
AMPDF
CRVH
4060
001203
CNE
8952